Clinical diagnosis: Fragility hip fracture
Clinical diagnosis: Fragility fracture long bones
Clinical diagnosis: Acute vertebral fragility fracture
Opportunistic/morphometric diagnosis-Silent vertebral fractures
Densitometric diagnosis: DXA scans
Osteopenia: Individualizing treatment-Part I
Osteopenia: Individualizing treatment-Part II
Osteopenia: Individualizing treatment-Part III : When silent vertebral compression fractures override the densitometric diagnosis
Osteopenia: Individualizing treatment-Part IV
Screening for osteoporosis
Oral bisphosphonates-Initiating and maintaining treatment
Oral bisphosphonates-Drug holidays and discontinuing therapy
Oral bisphosphonates-Long term: 13 years
Oral bisphosphonates-Lack of response
Zoledronic acid-Annual infusions
Receptor activator of nuclear factor kappa-B ligand (RANK-L) inhibitor-Denosumab
Sclerostin inhibitor (SERM): Raloxifene
Sclerostin inhibitor (SERM): Romosozumab
Parathyroid hormone analogs
Atypical femoral fractures
Osteonecrosis of the jaw : Nonhealing cavity after tooth extraction
Drug holidays
Osteoporosis in men
Premenopausal women with low bone mass
Osteoporosis in older adults
Low bone mass and osteoporosis in young adults
Iatrogenic osteoporosis
Primary hyperparathyroidism
Calcium and vitamin D disorders
Calcium and vitamin D disorders: Part II: Hypovitaminosis D
Calcium and vitamin D disorders: Part III: From hypovitaminosis to hypervitaminosis D
Magnesium
Physical exercise and bone health
Falls-Part I-Endogenous causes
Falls-Part II-Environmental hazards.